Clinical and serological findings of giant-cell arteritis

被引:0
作者
Vaith, P. [1 ]
Warnatz, K. [1 ]
机构
[1] Univ Freiburg Klinikum, Med Klin, Abt Rheumatol & Klin Immunol, D-79106 Freiburg, Germany
来源
ZEITSCHRIFT FUR RHEUMATOLOGIE | 2009年 / 68卷 / 02期
关键词
Giant cell arteritis; Polymyalgia rheumatica; Vasculitis; C-reactive protein; C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; POSITRON-EMISSION-TOMOGRAPHY; COMPLICATION AORTIC-ANEURYSM; POLYMYALGIA-RHEUMATICA; TEMPORAL ARTERITIS; CLASSIFICATION; INVOLVEMENT; PREVALENCE; DISSECTION;
D O I
10.1007/s00393-008-0377-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) frequently appears as cranial arteritis (eg. temporal arteritis) with headache, pain on chewing and visual disturbances. In addition, extracranial manifestations are often observed leading to aneurysmatic dilatations and dissections of the aorta as well as stenoses of large thoracic, abdominal or limb arteries. The vascular signs are accompanied by general disease symptoms, e. g. malaise, elevated temperatures, weight loss and depression. Polymyalgia rheumatica (PMR) is the most frequent rheumatic manifestation of GCA but also occurs independently from GCA. The structural correlate for the PMR symptoms is first and foremost extra-articular inflammation (tenosynovitis, bursitis) of large joints and the vertebral column (interspinal bursitis). In addition, vasculitis of large arteries in PMR must be considered particularly in the presence of high inflammatory activity. While specific laboratory markers for GCA and PMR are lacking elevated values for the erythrocyte sedimentation rate and C-reactive protein are present in almost all patients at disease onset. Besides the clinical evaluation, the serological acute phase reaction represents the main parameter for the course during therapy of this relatively frequent disease in elderly people.
引用
收藏
页码:124 / +
页数:7
相关论文
共 50 条
  • [21] The spectrum of vascular involvement in giant-cell arteritis: clinical consequences of detrimental vascular remodelling at different sites
    Cid, Maria C.
    Prieto-Gonzalez, Sergio
    Arguis, Pedro
    Espigol-Frigole, Georgina
    Butjosa, Montserrat
    Hernandez-Rodriguez, Jose
    Segarra, Marta
    Lozano, Ester
    Garcia-Martinez, Ana
    APMIS, 2009, 117 : 10 - 20
  • [22] Giant Cell Arteritis
    Ness, Thomas
    Noelle, Bernhard
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2024, 241 (05) : 644 - 652
  • [23] Giant Cell Arteritis
    Smith, Jonathan H.
    Swanson, Jerry W.
    HEADACHE, 2014, 54 (08): : 1273 - 1289
  • [24] AORTIC DISSECTION IN GIANT-CELL ARTERITIS
    LIU, G
    SHUPAK, R
    CHIU, BKY
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 1995, 25 (03) : 160 - 171
  • [25] New diagnostic and prognostic tools in giant-cell arteritis
    de Boysson, H.
    REVUE DE MEDECINE INTERNE, 2016, 37 : A28 - A31
  • [26] High risk and low prevalence diseases: Giant cell arteritis
    Lacy, Aaron
    Nelson, Rachel
    Koyfman, Alex
    Long, Brit
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 58 : 135 - 140
  • [27] Primary Care Vasculitis Polymyalgia Rheumatica and Giant Cell Arteritis
    Pioro, Mathilde H.
    PRIMARY CARE, 2018, 45 (02): : 305 - +
  • [28] Clinical Signs and Laboratory Findings of Polymyalgia Rheumatica and Giant Cell Arteritis
    Keysser, G.
    AKTUELLE RHEUMATOLOGIE, 2014, 39 (04) : 223 - 226
  • [29] INTRACRANIAL GIANT-CELL ARTERITIS
    RUSSI, E
    AEBI, M
    KRAUSRUPPERT, R
    MUMENTHALER, M
    JOURNAL OF NEUROLOGY, 1979, 221 (04) : 219 - 224
  • [30] CT analysis of the aorta in giant-cell arteritis: a case-control study
    Berthod, Pierre Emmanuel
    Aho-Glele, Serge
    Ornetti, Paul
    Chevallier, Olivier
    Devilliers, Herve
    Ricolfi, Frederic
    Bonnotte, Bernard
    Loffroy, Romaric
    Samson, Maxime
    EUROPEAN RADIOLOGY, 2018, 28 (09) : 3676 - 3684